Verification evidence is still being completed.
PDF / print export
HansaBioMed Life Sciences
Tallinn, Estonia
- Verified lead
- Paolo Guazzi
- Lead status
- STATUS: VERIFIED MARCH 2026
- Leadership verification
- Chief Operating Officer
- 2026 technical specialization
- Extracellular Vesicles, Exosome Isolation, and Nanoparticle Research Products
- Review cycle
- May 2026
- Full address
- Maealuse 2/1, 12618 Tallinn, Estonia
- Site coordinates
- Verification evidence is still being completed.
- Editorial review
- Memel Biotech editorial review
- Official leadership source
- Official HansaBioMed news page confirming the current published operating lead in Tallinn.
- Editorial note
- HansaBioMed strengthens the Estonia biotech layer with an official COO disclosure, a source-backed Tallinn operating address, and a long-standing extracellular-vesicle product and research platform.
Extracellular Vesicles, Exosome Isolation, and Nanoparticle Research Products
Business Registry ID 12993514, VAT EE101867663, Research-grade EV and exosome materials platform
HansaBioMed strengthens the Estonia biotech layer with an official COO disclosure, a source-backed Tallinn operating address, and a long-standing extracellular-vesicle product and research platform.
Review coverage
Leadership
Facility
Certifications
Capabilities
Partners
Sources
Quality
Editorial verificationMemel Biotech directory review sign-off
Report generated02 Jun 2026, 01:40
HansaBioMed strengthens the Estonia biotech layer with an official COO disclosure, a source-backed Tallinn operating address, and a long-standing extracellular-vesicle product and research platform.
- Lead
- Paolo Guazzi (verified ↗)
- Address
- Maealuse 2/1, 12618 Tallinn, Estonia (source ↗)
- Compliance
- Not yet on record
- Last reviewed
- 21 Mar 2026 (2mo ago)
- Scale
- Research-product platform for extracellular-vesicle science
- Capabilities
- Extracellular Vesicle Products · Exosome Isolation and Analysis Support · Research Collaboration and EV Workflow Development
- Founded
- 2007
- Headcount
- 11-50
- Company page (open ↗)
Clinical profileSTATUS: VERIFIED MARCH 2026
Paolo Guazzi
Chief Operating Officer
Full addressMaealuse 2/1, 12618 Tallinn, Estonia
Site coordinatesVerification evidence is still being completed.
Review cycleMay 2026
Physical site source
Official HansaBioMed contact page listing the Maealuse 2/1 Tallinn site.
Open sourceResearch-product platform for extracellular-vesicle science
Tallinn, Estonia. Extracellular Vesicles, Exosome Isolation, and Nanoparticle Research Products. Review completed on 21 Mar 2026.
Estonian business registry and internal life-science product quality controls
Business Registry ID 12993514, VAT EE101867663, Research-grade EV and exosome materials platform
Extracellular Vesicles, Exosome Isolation, and Nanoparticle Research Products
HansaBioMed strengthens the Estonia biotech layer with an official COO disclosure, a source-backed Tallinn operating address, and a long-standing extracellular-vesicle product and research platform.
Editorial note
HansaBioMed strengthens the Estonia biotech layer with an official COO disclosure, a source-backed Tallinn operating address, and a long-standing extracellular-vesicle product and research platform.
FULL TRUST REVIEW COMPLETE
Shown only when all seven trust checks are fully mapped in the directory.
Current review cycleMarch 2026
Capabilities
Core capabilities
Primary declared technical activities and areas of operating focus.
Extracellular Vesicle Products
Exosome Isolation and Analysis Support
Research Collaboration and EV Workflow Development
Verification source dossier
Verification source dossier
Official source set used to support leadership, physical-site, certification, and watch-note evidence.
Infrastructure
Declared infrastructure
EV and exosome product workflows
Isolation and characterization product lines
Tallinn laboratory and support operation
Regulatory posture
Quality system coverage
GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.
- GMP
- REVIEW IN PROGRESS 2026
- GLP
- REVIEW IN PROGRESS 2026
- ISO-13485
- REVIEW IN PROGRESS 2026
- FDA-Inspected
- REVIEW IN PROGRESS 2026
Verification history
Verification history
21 Mar 2026: Executive identity confirmed via official management disclosure.
21 Mar 2026: Full trust review completed.
FAQ
Frequently asked questions
- Where is HansaBioMed Life Sciences located?
- HansaBioMed Life Sciences operates from Maealuse 2/1, 12618 Tallinn, Estonia, Tallinn, Estonia.
- Who runs HansaBioMed Life Sciences?
- HansaBioMed Life Sciences is led by Paolo Guazzi, Chief Operating Officer. Verified 21 Mar 2026.
- What does HansaBioMed Life Sciences do?
- HansaBioMed strengthens the Estonia biotech layer with an official COO disclosure, a source-backed Tallinn operating address, and a long-standing extracellular-vesicle product and research platform. Core capabilities: Extracellular Vesicle Products, Exosome Isolation and Analysis Support, Research Collaboration and EV Workflow Development.
Editorial context
Related technical briefs
Briefs that name Tallinn as a covered market or city.